Background: Shigellosis according to European Centre for Disease Control (ECDC) Report is registered in all countries of the European Union (EU) and of the European Free Trade Association (EFTA) with exception of Italy and Luxemburg. The incidence rate in Poland below 0.1/100 000 of population is the lowest among the EU/EFTA countries.
Aim: To assess epidemiological situation of shigellosis in Poland in 2012 in comparison to preceding years.
Materials And Methods: An assessment of the epidemiological situation of shigellosis was based on the results from an analysis of the yearly annual bulletins: "Infectious diseases and poisonings in Poland in 2012", reports from bacteriological laboratories and reports from individual cases and epidemiological investigations of outbreaks linked to shigellosis, sent by Sanitary-Epidemiological Stations to the Department of Epidemiology at NIZP-PZH.
Results: In 2012 the tendency that the number of registered cases of shigellosis was lower than in the former years continued - only 13 confirmed cases of shigellosis were registered (incidence rate 0.03 per 100 000 inhabitantsbut in the previous year the 18 cases ( incidence rate 0.05). Cases were registered only by 6 provinces, most of the cases by the Lodz province - 4. All together 5 persons nearly 40% were infected in travel to the foreign countries. According to data from laboratories of Sanitary-Epidemiological Stations, Shigella was detected only 4 convalescents and 2 carriers. All cases of shigellosis registered in 2012, were confirmed by a hospital laboratory or a private laboratory.
Conclusions: In our opinion the above mentioned data concerning the cases of shigellosis in Poland in 2012 are not reflecting the true epidemiological situation of shigellosis in Poland. The sanitary situation was changing nearly every year for better than in former years but the surveillance of dysentery require more active epidemiological measures.
Download full-text PDF |
Source |
---|
Sci Rep
October 2024
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla Str. 12, 53-114, Wroclaw, Poland.
The anti-Shigella vaccine is one of the WHO's top priorities. Every year the disease kills more than 200,000 people worldwide and poses a serious threat to children under 5 years of age and the elderly. Increasing antibiotic resistance and limitations in diagnostics emphasize the need to develop an effective vaccine.
View Article and Find Full Text PDFPrzegl Epidemiol
July 2022
National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.
Aim: The purpose of this study is evaluation of the epidemiological situation of shigellosis in Poland in years 2018-2019, comparing to previous years.
Materials And Methods: The evaluation of epidemiological situation of shigellosis in Poland was based on analysis of data from epidemiological surveillance collected in questionnaires and sent to the Department of Epidemiology of Infectious Diseases and Surveillance NIPH NIH-NRI by sanitary stations. Once a case was reported on a ZLK-1 and/or ZLB-1 form to the appropriate State Sanitary Inspector, an epidemiological investigation was conducted by collecting additional information from medical records and from the patient interview.
Nutrients
November 2021
Department of Bacterial Molecular Genetics, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
Cruciferous vegetables, widely present in daily diets, are a rich source of organosulfur compounds with proven health benefits, especially chemopreventive or antioxidative effects. Isothiocyanate derivatives (ITCs) exhibit a broad spectrum of biological and pharmacological activity and recently, their antibacterial properties have been of particular importance. Here, we have focused on the anti-shigellosis activity of sulforaphane (SFN) and phenethyl ITC (PEITC).
View Article and Find Full Text PDFPLoS Pathog
December 2019
Section of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Shigella flexneri is historically regarded as the primary agent of bacillary dysentery, yet the closely-related Shigella sonnei is replacing S. flexneri, especially in developing countries. The underlying reasons for this dramatic shift are mostly unknown.
View Article and Find Full Text PDFInt J STD AIDS
July 2019
1 Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, Krakow, Poland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!